B
RMD icon

Baird’s ResMed RMD Stock Holding History

Baird’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$477K Sell
6,650
-100
-1% -$6.5K ﹤0.01% 972
2014
Q4 		$379K Buy
6,750
+650
+11% +$33.9K ﹤0.01% 1034
2014
Q3 		$301K Sell
6,100
-600
-9% -$30.6K ﹤0.01% 978
2014
Q2 		$339K Hold
6,700
– – ﹤0.01% 949
2014
Q1 		$299K Hold
6,700
– – ﹤0.01% 983
2013
Q4 		$315K Hold
6,700
– – 0.01% 954
2013
Q3 		$354K Sell
6,700
-300
-4% -$14.6K 0.01% 896
2013
Q2 		$316K Buy
+7,000
New +$332K 0.01% 895

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baird's RMD Position: Q1 2015 in Review

Baird reduced its ResMed (RMD) stake by 1.5% in Q1 2015, selling an estimated $6.5K and leaving 6,650 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Baird first reported a position in RMD in Q2 2013 and has held it in 8 quarters since. 325 funds tracked by Wall St. Rank hold RMD as of Q1 2015.

  • Baird held 6,650 shares of ResMed worth $477K as of Q1 2015.
  • Baird sold 100 ResMed shares in Q1 2015, an estimated $6.5K.
  • ResMed made up ﹤0.01% of Baird's portfolio in Q1 2015, its #972 holding.
  • Baird first reported a position in ResMed in Q2 2013 and has held it in 8 quarters since.
  • 325 funds tracked by Wall St. Rank held ResMed as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.